AKT Axis, miR-21, and RECK Play Pivotal Roles in Dihydroartemisinin Killing Malignant Glioma Cells

by Ying-Ying Shao, Tao-Lan Zhang, Lan-Xiang Wu, He-Cun Zou, Shuang Li, Jin Huang, Hong-Hao Zhou
Published 2017-02-01

A four‐factor immune risk score signature predicts the clinical outcome of patients with spinal chordoma

by Ming‐Xiang Zou, Yue Pan, Wei Huang, Tao‐Lan Zhang, David Escobar, Xiao‐Bin Wang, Yi Jiang, Xiao‐Ling She, Guo‐Hua Lv, Jing Li
Published 2020-03-01

Clinicopathological and Prognostic Characteristics in Dedifferentiated/Poorly Differentiated Chordomas: A Pooled Analysis of Individual Patient Data From 58 Studies and Comparison...

by Fu-Sheng Liu, Fu-Sheng Liu, Bo-Wen Zheng, Bo-Wen Zheng, Tao-Lan Zhang, Jing Li, Guo-Hua Lv, Yi-Guo Yan, Wei Huang, Ming-Xiang Zou
Published 2021-08-01

Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma

by Wei Huang, Wei Huang, Yi-Guo Yan, Wen-Jun Wang, Zhi-Hua Ouyang, Xue-Lin Li, Tao-Lan Zhang, Xiao-Bin Wang, Bing Wang, Guo-Hua Lv, Jing Li, Ming-Xiang Zou, Ming-Xiang Zou
Published 2020-10-01